OpenURL Connection Search

Select item for more details and to access through your institution.

The FLUENT study design: investigating immune cell subset and neurofilament changes in patients with relapsing multiple sclerosis treated with fingolimod.
Published in:
Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 1, p. 1, doi. 10.1177/2055217318819245
By:
- Cohen, Jeffrey A.;
- Bar-Or, Amit;
- Cree, Bruce A. C.;
- Mao-Draayer, Yang;
- Han, May H.;
- Singer, Barry;
- Jannu, Ann;
- Kolodny, Scott;
- Meng, Xiangyi;
- Winger, Ryan C.
Publication type:
Article
The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20-Year Data from the U.S. Glatiramer Acetate Extension Study.
Published in:
2017
By:
- Khan, Omar;
- Seraji‐Bozorgzad, Navid;
- Bao, Fen;
- Razmjou, Sara;
- Caon, Christina;
- Santiago, Carla;
- Latif, Zahid;
- Aronov, Rimma;
- Zak, Imad;
- Ashtamker, Natalia;
- Kolodny, Scott;
- Ford, Corey;
- Sidi, Yulia
Publication type:
journal article
Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study.
Published in:
Multiple Sclerosis Journal, 2017, v. 23, n. 6, p. 818, doi. 10.1177/1352458516664033
By:
- Khan, Omar;
- Rieckmann, Peter;
- Boyko, Alexey;
- Selmaj, Krzysztof;
- Ashtamker, Natalia;
- Davis, Mat D.;
- Kolodny, Scott;
- Zivadinov, Robert
Publication type:
Article
Avatrombopag treatment response in patients with immune thrombocytopenia: the REAL-AVA 1.0 study.
Published in:
Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207231179856
By:
- Oladapo, Abiola;
- Kolodny, Scott;
- Vredenburg, Michael;
- Swallow, Elyse;
- Goldschmidt, Debbie;
- Sarathy, Kirthana;
- Lopez, Priscilla;
- Maitland, Hillary;
- Yee, John
Publication type:
Article
Utilization and Treatment Patterns of Disease-Modifying Therapy in Pediatric Patients with Multiple Sclerosis in the United States.
Published in:
International Journal of MS Care, 2021, v. 23, n. 3, p. 101, doi. 10.7224/1537-2073.2019-095
By:
- Greenberg, Benjamin;
- Kolodny, Scott;
- Mengru Wang;
- Deshpande, Chinmay
Publication type:
Article
(DXT78) The FLUENT Study: Changes in Immune Cell Profile, and in Clinical and Safety Outcomes, in Fingolimod-Treated Patients with Relapsing Multiple Sclerosis.
Published in:
International Journal of MS Care, 2020, v. 22, n. S2, p. 44
By:
- Yang Mao-Draayer;
- Cohen, Jeffrey A.;
- Bar-Or, Amit;
- Han, May H.;
- Singer, Barry A.;
- Jaitly, Nina;
- Kolodny, Scott;
- Elam, Chelsea;
- Xiangyi Meng;
- Ziehn, Marina;
- Cree, Bruce A. C.
Publication type:
Article
Safety Considerations for Follow-On Non-Biologic Complex Drugs.
Published in:
Applied Clinical Trials, 2015, v. 24, n. 6/7, p. 54
By:
- Kolodny, Scott
Publication type:
Article
Correction to: Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic.
Published in:
2019
By:
- Brown, Brandon;
- Weiss, Jamie L.;
- Kolodny, Scott;
- Meng, Xiangyi;
- Williams, Ian M.;
- Osborne, John A.
Publication type:
journal article
Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic.
Published in:
2019
By:
- Brown, Brandon;
- Weiss, Jamie L.;
- Kolodny, Scott;
- Meng, Xiangyi;
- Williams, Ian M.;
- Osborne, John A.
Publication type:
journal article

Found: 9